Fig. 2From: Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effectIn-vitro drug release studies of optimized carvedilol-loaded ethosomal formulation (EF1). The experiments were carried out in triplicate and results are shown as mean ± SEMBack to article page